1.
J Natl Compr Canc Netw
; 22(1D): e240001, 2024 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38244272
RESUMO
The treatment of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma (WM/LPL) has evolved to include several new options. The NCCN Guidelines for WM/LPL provide a framework on which to base decisions regarding diagnosis, treatment, assessment of response to treatment, and follow-up of both newly diagnosed and previously treated WM/LPL.